FDA hits leukemia study with partial clinical hold
The FDA has placed a partial clinical hold on Xencor's Phase I study of XmAb14045 on safety concerns.
22nd February 2019
Latest news
Morphic and Janssen team up for integrin therapies
Morphic and Janssen have entered into a research and development collaboration to discover and develop novel integrin therapeutics.
22nd February 2019
Pfizer adjusts Xeljanz trial due to pulmonary embolism risk
Pfizer has announced plans to lower its Xeljanz (tofacitinib) trial dosing from 10mg twice-daily to 5mg twice-daily, after pulmonary embolisms were found to be more frequent among patients treated with the higher dose.
22nd February 2019
Brineura hit with NICE rejection
NICE is rejecting NHS funding for a £500,000-a-year drug to treat Batten disease on concerns over its long-term effectiveness.
22nd February 2019
MHRA issues drug safety warning for Neo-mercazole in pregnancy
The MHRA has issued a drug safety warning for Neo-mercazole in pregnancy, urging women of childbearing potential to use effective contraception during treatment
22nd February 2019
NHS implements new AI code of conduct
A new code of conduct will ensure that only the best and safest data-driven technologies are used by the NHS, the government says.
21st February 2019
Young people in UK ‘suffering from long-term conditions’ despite healthier life choices
Young people in the UK are making healthier life choices for themselves than before, but are more likely to have a poor quality of life, a new study has found.
21st February 2019
Cell therapy trial shows 'significant' vision restoration
ReNeuron has found ‘significant restoration of vision’ in patients with retinitis pigmentosa given its human retinal progenitor cells (hRPC) cell therapy.
21st February 2019
European Medicines Agency forced to pay London lease
The EMA has lost a high court battle to cancel its £500-million long-term office lease in London.
21st February 2019
Abbott and Novo Nordisk strike diabetes digital solution deal
Abbott and Novo Nordisk have entered into a partnership to provide integrated digital solutions to people with diabetes, using insulin.
21st February 2019
New cancer drug payment system could speed up treatment
A new report suggests that paying for cancer drugs based on how well they work in practice could help patients get new treatments faster.
21st February 2019
FDA thumbs up for Esperoct in haemophilia A
Novo Nordisk has received US approval for haemophilia A drug Esperoct.
21st February 2019
Gov unveils launch of NHSX for digital, data and tech
The government has announced plans to create a new joint organisation for digital, data and technology, to be called NHSX.
20th February 2019
Last chance to get your entry in for the 2019 Clinical Researcher of the Year – The Americas competition
This established, challenging, and free-to-enter competition will close for entry on the 25th February – don’t miss out on this great personal development opportunity.
20th February 2019
FDA Priority Review for Roche’s entrectinib in cancer treatment
Roche has announced that the FDA has granted Priority Review for entrectinib as a treatment for NTRK fusion-positive, locally advanced or metastatic solid tumours, and to treat metastatic ROS1-positive non-small-cell lung cancer.
20th February 2019
